- Report
- August 2021
Global
From €3652EUR$3,990USD£3,104GBP
- Report
- May 2022
- 226 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Report
- August 2024
- 99 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- March 2022
- 97 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- July 2024
- 155 Pages
Global
From €3307EUR$3,613USD£2,810GBP
€3890EUR$4,250USD£3,306GBP
- Report
- July 2024
- 260 Pages
Global
From €1701EUR$1,859USD£1,446GBP
€2430EUR$2,655USD£2,066GBP
- Report
- January 2024
- 250 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- December 2022
- 220 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- January 2022
- 141 Pages
France
From €2379EUR$2,598USD£2,022GBP
€3398EUR$3,712USD£2,888GBP
- Book
- March 2025
- 300 Pages
Australia
- Book
- November 2020
- 464 Pages
- Book
- July 2020
- 416 Pages
- Book
- March 2019
- 648 Pages
- Book
- November 2018
- 1088 Pages
- Book
- April 2016
- 576 Pages
- Book
- December 2014
- 280 Pages
- Book
- May 2013
- 424 Pages
- Book
- March 2012
- 600 Pages

Endometriosis is a condition in which the tissue that normally lines the uterus grows outside of the uterus, most commonly on the ovaries, fallopian tubes, and the tissue lining the pelvis. It is a common condition among women of reproductive age, and can cause pain, heavy menstrual bleeding, and infertility. Endometriosis is often treated with hormone therapy, surgery, or a combination of both.
The Endometriosis market within the context of Women's Health is a growing field, with a focus on providing treatments and therapies to improve the quality of life for those affected. Companies in this market are developing new treatments and therapies to address the symptoms of endometriosis, as well as researching new ways to diagnose and manage the condition.
Some companies in the Endometriosis market include AbbVie, Bayer, Allergan, and Myovant Sciences. Show Less Read more